Aura Biosciences, Inc.
AURA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$26,130 | -$27,019 | -$27,483 | -$25,834 |
| Dep. & Amort. | $280 | $286 | $291 | $291 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,688 | $3,833 | $3,514 | $2,937 |
| Change in WC | $1,963 | $2,027 | $423 | -$942 |
| Other Non-Cash | $55 | $99 | -$100 | -$404 |
| Operating Cash Flow | -$20,144 | -$20,774 | -$23,355 | -$23,952 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$45 | -$39 | -$187 | -$299 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$73,974 | -$9,984 | $0 | -$5 |
| Inv. Sales/Matur. | $30,000 | $30,000 | $30,000 | $29,999 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$44,019 | $19,977 | $29,813 | $29,695 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $3,287 | $69,929 | $96 | $543 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,076 | $0 | $0 | $0 |
| Financing Cash Flow | $4,363 | $69,929 | $96 | $543 |
| Forex Effect | -$14 | $9 | -$21 | $0 |
| Net Chg. in Cash | -$59,814 | $69,141 | $6,533 | $6,286 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $108,135 | $38,994 | $32,461 | $26,175 |
| End Cash | $48,321 | $108,135 | $38,994 | $32,461 |
| Free Cash Flow | -$20,189 | -$20,813 | -$23,542 | -$24,251 |